Nestle Health Science Plans Continuum Of Care
This article was originally published in The Tan Sheet
Executive Summary
Nestle's announcement that its Health Science division is buying gastrointestinal drug developer and diagnostics firm Prometheus Laboratories takes the food company in a new direction, raising questions about Nestle's possible pharmaceutical play.